Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Gastric bypass surgery in Management of Morbid Obesity
Hossam Amier El sayed Mohmed Ghorieb;
Abstract
SUMMARY & CONCLUSION
O
besity is defined as, a body mass index (BMI) of 30 kg/m2 or more. Morbid obesity is defined as a body mass index (BMI) of > 40 kg/m2 or BMI > 35 kg/m2 together with obesity-related disease.
Obesity is a worldwide epidemic, and is rapidly becoming one of the most serious chronic health problems world-wide. In the developed countries, a large proportion of the population are overweight, with approximately up 30 % of the population are affected by morbid obesity.
Clear understanding of the pathophysiology of morbid obesity is essential for management and prevention of this disease. The exact cause of obesity is unclear. However, there are many factors that contribute to the development of morbid obesity including personal, like age and gender, genetic, environmental, dietary, socioeconomic, behavioral, and drug-induced obesity.
Obesity is a chronic disease that causes serious medical co-morbidities. Such co-morbidities are associated with reduction of life expectancy, and quality of life. These co-morbidities include: cardiovascular dysfunction, hypertension, respiratory system dysfunction, osteoarthritis, diabetes mellitus, gastroesophageal reflux disease, renal dysfunction, neurological disability, and hernia. There is also an increased risk for the development of certain types of cancer associated with overweight. In addition, obesity is associated with an increased risk of mortality at all ages. Therefore, it is considered as one of the leading preventable cause of death worldwide.
Non-surgical approaches to treatment of clinically severe obesity include various combinations of low- or very low-calorie diets, behavioral modification, exercise, and pharmacologic agents. In addition to weight reduction regimens, co-morbid factors such as diabetes mellitus, hypertension and dyslipidemia, can be treated by usual medical methods.
Non-surgical treatment of clinically severe obesity aims to create a caloric deficit sufficient to result in both permanent weight loss and reduction of weight-related risk factors or co-morbidity. These methods have limited success in achieving sustained weight loss. Therefore the National Institutes of Health established guidelines for the surgical therapy of morbid obesity, now referred to as bariatric surgery.
Bariatric surgery is the only effective means of ac
O
besity is defined as, a body mass index (BMI) of 30 kg/m2 or more. Morbid obesity is defined as a body mass index (BMI) of > 40 kg/m2 or BMI > 35 kg/m2 together with obesity-related disease.
Obesity is a worldwide epidemic, and is rapidly becoming one of the most serious chronic health problems world-wide. In the developed countries, a large proportion of the population are overweight, with approximately up 30 % of the population are affected by morbid obesity.
Clear understanding of the pathophysiology of morbid obesity is essential for management and prevention of this disease. The exact cause of obesity is unclear. However, there are many factors that contribute to the development of morbid obesity including personal, like age and gender, genetic, environmental, dietary, socioeconomic, behavioral, and drug-induced obesity.
Obesity is a chronic disease that causes serious medical co-morbidities. Such co-morbidities are associated with reduction of life expectancy, and quality of life. These co-morbidities include: cardiovascular dysfunction, hypertension, respiratory system dysfunction, osteoarthritis, diabetes mellitus, gastroesophageal reflux disease, renal dysfunction, neurological disability, and hernia. There is also an increased risk for the development of certain types of cancer associated with overweight. In addition, obesity is associated with an increased risk of mortality at all ages. Therefore, it is considered as one of the leading preventable cause of death worldwide.
Non-surgical approaches to treatment of clinically severe obesity include various combinations of low- or very low-calorie diets, behavioral modification, exercise, and pharmacologic agents. In addition to weight reduction regimens, co-morbid factors such as diabetes mellitus, hypertension and dyslipidemia, can be treated by usual medical methods.
Non-surgical treatment of clinically severe obesity aims to create a caloric deficit sufficient to result in both permanent weight loss and reduction of weight-related risk factors or co-morbidity. These methods have limited success in achieving sustained weight loss. Therefore the National Institutes of Health established guidelines for the surgical therapy of morbid obesity, now referred to as bariatric surgery.
Bariatric surgery is the only effective means of ac
Other data
| Title | Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Gastric bypass surgery in Management of Morbid Obesity | Other Titles | عملية تكميم المعدة بالمنظار الجراحى مقابل عملية تحويل مسار المعدة بالمنظار الجراحى فى علاج السمنة المفرطة | Authors | Hossam Amier El sayed Mohmed Ghorieb | Issue Date | 2015 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.